Catherine Crofts, PhD (AUT), MPhil (AUUT), BPharm (Otago), PGDipClinPharm RegPharmNZ

Share this

Catherine is an academic pharmacist (RegPharmNZ #7184) with a strong interest in hyperinsulinaemia as a unifying feature of metabolic disease. Her current research focuses on the non-glycaemic challenges of hyperinsulinaemia – such as its impact on bones. She has a strong interest in good data collection and interpretation, leading to research in wearable devices and genAI tools.

An upcoming research topic for Catherine will be on the GLP1-receptor agonists, as she is concerned about their use. She sees the parallels between GLP1 use and that of insulin: expanding use without understanding their mechanism of action in the evolutionary sense, leading to resistance and unforeseen sequelae which increases disease burden in the long-term.

Catherine Crofts

Presentations

‘Beyond Insulin’  – Low Carb Down Under 2019

Research publications and dissemination 

Peer-reviewed journal articles

  • Zinn, C., …..Crofts, C., . . Schofield, G. (2024). Redefining diabetes care: Evaluating the impact of a carbohydrate-reduction, health coach approach model in New Zealand. Journal of Diabetes Research, 2024. doi:10.1155/jdr/4843889
  • Passfield, G., Mackay, L., Crofts, C., & Schofield, G. (2024). A comparison of sleep metrics from mid-thigh and low-back accelerometers to wrist based data using open-source algorithms. doi:10.1101/2024.11.10.24317079
  • Ali, H., Niazi, I. K., Russell, B. K., Crofts, C., Madanian, S., & White, D. (2023). Review of time domain electronic medical record taxonomies in the application of machine learning. Electronics, 12(3). doi:10.3390/electronics12030554
  • North, S. M., Crofts, C., & Zinn, C. (2022). Hyperinsulinaemia in pregnancy and gestational outcomes: A case series. Journal of Insulin Resistance, 5(1). doi:10.4102/jir.v5i1.69
  • Zinn, C., & Crofts, C. (2022). Interpreting quantification: Is this the Achilles heel of insulin diagnostics?. In Journal of Insulin Resistance (Vol. 5, Iss. 1). AOSIS. doi:10.4102/jir.v5i1.70
  • North, S., Crofts, C., & Zinn, C. (2022). Health professionals’ views and experiences around the dietary and lifestyle management of gestational diabetes in New Zealand. Nutrition & Dietetics, 79(2), 255-264. doi:10.1111/1747-0080.12719
  • North, S., Crofts, C., Thoma, C., & Zinn, C. (2022). The role of maternal diet on offspring hyperinsulinaemia and adiposity after birth: A systematic review of randomised controlled trials. Journal of Developmental Origins of Health and Disease, 13(5), 527-540. doi:10.1017/S2040174421000623
  • North, S., Zinn, C., & Crofts, C. (2021). Hyperinsulinemia during pregnancy across varying degrees of glucose tolerance: An examination of the Kraft database. Journal of Obstetrics and Gynaecology Research, 47(5), 1719-1726. doi:10.1111/jog.14731
  • Cooper, I. D., Brookler, K. H., & Crofts, C. A. P. (2021). Rethinking fragility fractures in type 2 diabetes: The link between hyperinsulinaemia and osteofragilitas. Biomedicines, 9(9). doi:10.3390/biomedicines9091165
  • Cooper, I. D., Brookler, K. H., Kyriakidou, Y., Elliott, B. T., & Crofts, C. A. P. (2021). Metabolic phenotypes and step by step evolution of type 2 diabetes: A new paradigm. Biomedicines, 9(7). doi:10.3390/biomedicines9070800
  • Cooper, I. D., Crofts, C. A. P., DiNicolantonio, J. J., Malhotra, A., Elliott, B., Kyriakidou, Y., & Brookler, K. H. (2020). Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management. Open Heart, 7(2). doi:10.1136/openhrt-2020-001356
  • Guildford, L., Crofts, C., & Lu, J. (2020). Can the molar insulin: c-Peptide ratio be used to predict hyperinsulinaemia?. Biomedicines, 8(5). doi:10.3390/biomedicines8050108

Peer-reviewed book chapters, books edited

  • Noakes, T. D., Crofts, C., & Ben-Dor, M. (2023). Understanding human diet, disease, and insulin resistance: Scientific and evolutionary perspectives. In T. D. Noakes, T. Murphy, N. Wellington, H. Kajee, J. Bullen, S. Rice, & C. Egnos (Eds.), Ketogenic: The science of therapeutic carbohydrate restriction in human health (pp. 3-69). Elsevier. doi:10.1016/b978-0-12-821617-0.00011-5

Refereed conference proceedings

  • Crofts, C. and D. White (2018). Aristotle in action: How we made our Team stronger than the sum of its parts. All Together Better Health IX. Auckland 
  • Crofts, C (2016) Metabolic Disease: Do We Need to Re-Adjust Our Targeting Strategies New Zealand Hospital Pharmacist Association. Christchurch
  • Crofts, C (2015) Diagnosing hyperinsulinaemia AUT Postgraduate Symposium  Auckland 

Other forms of dissemination (reports for clients, technical reports, popular press, etc)

  • Invited speaker: Crofts, C. (2022). Insulin, glucagon and other metabolites: The big picture. In Future of Medicine. Auckland: PreKure. Retrieved from  https://www.youtube.com/watch?v=AhvijxOlSe0&t=12s
  • Poster presentation: North, S., Crofts, C., & Zinn, C. (2021). Hyperinsulinaemia during pregnancy across varying degrees of glucose tolerance: An examination of the kraft database. In New Zealand Society for the Study of Diabetes Annual Scientific Meeting 2021. Wellington: New Zealand Society for the Study of Diabetes. Retrieved from https://www.ivvy.com.au/event/NZSSD2021/
  • Poster presentation: Crofts, C. (2021). Type 2 diabetes IS hyperinsulinaemia: Analysis of the Kraft database. In The New Zealand Society for the Study of Diabetes. Wellington.
  • Invited speaker to Low-Carb Breckenridge (2018), Redefining Diabetes (Swiss Re, 2018) Low-Carb Gold Coast (2018), Low-Carb Auckland (2014), National Gerontology Conference (Auckland, 2009)
  • Invited attendee to Food for Thought (Swiss Re, 2018)
  • Schofield, G., Henderson, G., Crofts, C., & Thornley, S. (2016). What are we to think when results from mouse research contradict those from human experiments and clinical practice? Nutrition & Diabetes, 6(8), e224.
  • Schofield, G., Henderson, G., & Crofts, C. (2016). Schofield, G., Henderson, G., & Crofts, C. (2016). Beyond salt–where next for hypertension epidemiology? The Lancet, 388(10056), 2110.
  • Lifestyle before medication (www.pharmacistcatherine.net)  Popular press Blog.

Prodromal Diabetes Mitigation and Prevention Strategy

Dr Catherine Croft – Prodromal T2D prevention (002)Download